Corporate Accountability

Obamacare Court Battle: Two Justices, Three Issues to Watch

By Todd Ruger

 

Both advocates and foes of the health care law will pay special attention to how two justices navigate at least three key issues during Supreme Court oral arguments today.

 

The focus was expected to be mainly on Chief Justice John G. Roberts Jr.—the key vote in the 2012 case that upheld the health care law in a 5-4 ruling—and Justice Anthony M. Kennedy, who has a reputation as a swing vote….

 

Kennedy has been particularly concerned about states’ rights, and the defenders of the law have made that an issue in this case, [CAC Appellate Counsel Brianne] Gorod said. “I think it could be very telling if [Kennedy] is concerned about that issue in the case,” Gorod said of the argument. “It’s one that could resonate with any number of them, particularly the conservative justices.”

More from Corporate Accountability

Corporate Accountability
September 9, 2025

ENFORCEMENT ACTIONS—Fifth Circuit rejects petition challenging OCC authority to enforce national banking rules

Wolters Kluwer VitalLaw
The court distinguished the national banking regulatory regime from the SEC’s antifraud provision in Jarkesy and the...
Corporate Accountability
July 11, 2025

This Group’s Record in Front of the Roberts Court Is Mind-Boggling

Slate
In a provocative dissenting opinion, Justice Ketanji Brown Jackson recently called out her colleagues on the Supreme Court...
By: Ana Builes, Brian R. Frazelle
Corporate Accountability
July 2, 2025

Moneyed Interests Still Prevail at the Supreme Court (2024-2025 Term)

The Court Continues to Favor Corporations over Workers, Consumers, and the Environment.
By: Brian R. Frazelle, Ana Builes
Corporate Accountability
U.S. Court of Appeals for the Third Circuit

Novartis v. Secretary United States Department of Health and Human Services

In Novartis v. Secretary United States Department of Health and Human Services, the United States Court of Appeals for the Third Circuit considered whether the Inflation Reduction Act’s Medicare drug price negotiation program is an unconstitutional...
Corporate Accountability
January 28, 2025

Federal Deposit Insurance as Jarkesy Waiver

Yale Journal on Regulation
An argument lurking just beneath the surface in a pending Fifth Circuit case could stem...
Corporate Accountability
U.S. Court of Appeals for the Second Circuit

Boehringer Ingelheim v. Department of Health and Human Services

In Boehringer Ingelheim v. Department of Health and Human Services, the United States Court of Appeals for the Second Circuit considered whether the Inflation Reduction Act’s Medicare drug price negotiation program is an unconstitutional taking...